Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Susan K Foltin"'
Autor:
Osei Owusu-Afriyie, W K B A Owiredu, Kwabena Owusu-Danquah, Christine Komarck, Susan K Foltin, Rita Larsen-Reindorf, Emmanuel Acheampong, Solomon E Quayson, Mark E Prince, Jonathan B McHugh, Peter Donkor, Sofia D Merajver, J Chad Brenner
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209696 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0202790.].
Externí odkaz:
https://doaj.org/article/4d327545659a4505aeb1fa6756e75d5b
Autor:
Osei Owusu-Afriyie, W K B A Owiredu, Kwabena Owusu-Danquah, Christine Komarck, Susan K Foltin, Rita Larsen-Reindorf, Emmanuel Acheampong, Solomon E Quayson, Mark E Prince, Jonathan B McHugh, Peter Donkor, Sofia D Merajver, J Chad Brenner
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0202790 (2018)
BACKGROUND:Head and neck cancers include carcinomas of the oral cavity, larynx, sinonasal tract and nasopharynx. Studies on molecular expression of prognostic tumour markers in Ghana are scarce. The purpose of this study was to determine the expressi
Externí odkaz:
https://doaj.org/article/ca9d223538aa4d579b510b72ae6512d9
Autor:
Nicole L. Michmerhuizen, Megan L. Ludwig, Andrew C. Birkeland, Sai Nimmagadda, Jingyi Zhai, Jiayu Wang, Brittany M. Jewell, Dylan Genouw, Lindsay Remer, Daniel Kim, Susan K. Foltin, Apurva Bhangale, Aditi Kulkarni, Carol R. Bradford, Paul L. Swiecicki, Thomas E. Carey, Hui Jiang, J. Chad Brenner
Publikováno v:
Headneck. 44(5)
Head and neck squamous cell carcinoma (HNSCC) is a debilitating disease with poor survival. Although epidermal growth factor receptor (EGFR)-targeting antibody cetuximab improves survival in some settings, responses are limited suggesting that altern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48827582487d3cd1b57efab7d3457dc
https://pubmed.ncbi.nlm.nih.gov/35224804
https://pubmed.ncbi.nlm.nih.gov/35224804
Autor:
John N. Rauch, Susan K. Foltin, Libuse Oupicka, Matthew Dilsaver, Grigory S. Filonov, Gillian Lovell, Jasmine Trigg, Cicely L. Schramm
Publikováno v:
Cancer Research. 82:156-156
Dysregulation of signal transduction pathways is associated with cancer initiation, progression, and recurrence. The PI3K/Akt signaling pathway has been extensively investigated as a therapeutic target due to its mechanistic association with several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f538e8ef6a5b2a6ad2fe105ad4b2afb
https://doi.org/10.1158/1538-7445.am2022-156
https://doi.org/10.1158/1538-7445.am2022-156
Autor:
Nicole L. Michmerhuizen, J. Chad Brenner, Susan K. Foltin, Andrew G. Shuman, Matthew E. Spector, Jacqueline E. Mann, Thomas E. Carey, Megan L. Ludwig, Hui Jiang, Aditi Kulkarni, Samantha N. Devenport, Brittany M. Jewell, Rebecca C. Hoesli, Andrew C. Birkeland
Publikováno v:
Oral Oncology. 87:144-151
Objectives We sought to describe the genetic complexity of 14 UM-SCC oral cavity cancer cell lines that have remained uncharacterized despite being used as model systems for decades. Materials and Methods We performed exome sequencing on 14 oral cavi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd90500de1a3a1128da2805922eb729
https://doi.org/10.1016/j.oraloncology.2018.10.031
https://doi.org/10.1016/j.oraloncology.2018.10.031
Autor:
Lisa M. Pinatti, Apurva D. Bhangale, Megan L. Ludwig, Brittany M. Jewell, Andrew C. Birkeland, Hui Jiang, Lawence J. Marentette, Jonathan B. McHugh, Erin L. McKean, Aditi Kulkarni, J. Chad Brenner, Jingyi Zhai, Molly E. Heft Neal, Susan K. Foltin
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
BMC cancer, vol 21, iss 1
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
BMC cancer, vol 21, iss 1
Background Sinonasal Undifferentiated Carcinoma (SNUC) is a rare and aggressive skull base tumor with poor survival and limited treatment options. To date, targeted sequencing studies have identified IDH2 and SMARCB1 as potential driver alterations,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3cad75cad490a020c55c314dc7a431f
https://pubmed.ncbi.nlm.nih.gov/34051734
https://pubmed.ncbi.nlm.nih.gov/34051734
Autor:
Jingyi Zhai, Susan K. Foltin, J.C. Brenner, Elizabeth Gensterblum-Miller, Aditi Kulkarni, Collin Brummel, Daffyd Thomas, M E Heft Neal, J.B. McHugh, Hui Jiang, Apurva D. Bhangale, Joshua C. Smith
Publikováno v:
Oral Oncol
Objectives Salivary gland tumors are comprised of a diverse group of malignancies with widely varying prognoses. These cancers can be difficult to differentiate, especially in cases with limited potential for immunohistochemistry (IHC)-based characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34eb718d9aa668e97e1debf451ed0528
https://doi.org/10.1016/j.oraloncology.2021.105270
https://doi.org/10.1016/j.oraloncology.2021.105270
Autor:
Mark E. Prince, Carol R. Bradford, Susan K. Foltin, Paul L. Swiecicki, Keith A. Casper, J.C. Brenner, Andrew G. Shuman, Michelle Mierzwa, Kelly M. Malloy, Gregory T. Wolf, Rebecca C. Hoesli, Scott A. McLean, Matthew E. Spector, Steven B. Chinn, Joshua D. Smith, Andrew J. Rosko, Andrew C. Birkeland
Publikováno v:
Head & neck, vol 41, iss 2
BACKGROUND We sought to describe targeted DNA sequencing data of persistent/recurrent laryngeal squamous cell carcinoma (LSCC) and to compare gene-specific alteration frequencies with that of primary, untreated LSCC specimens from The Cancer Genome A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae0d8bf3c7cc1a10628626c41ea9887
https://escholarship.org/uc/item/8bt7w6sh
https://escholarship.org/uc/item/8bt7w6sh
Autor:
Jonathan B. McHugh, Ernest Adjei, Megan L. Ludwig, Lauren E. Merz, Evelyn Jiagge, Osei Owusu Afriyie, Susan K. Foltin, J. Chad Brenner, Sofia D. Merajver
Publikováno v:
Health Science Reports
Background and aims Conjunctival squamous cell carcinoma (CSCC) varies in incidence geographically from 0 to 1 case per 100 000 per year globally. Additionally, the incidence of CSCC is known to increase 49% for every 10° decrease in latitude. Since
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b6df4436212c67bc2dd535720aa270
http://europepmc.org/articles/PMC6375545
http://europepmc.org/articles/PMC6375545
Autor:
Yong X. Chen, Grigory S. Filonov, Ilya Kovalenko, Libuse Oupicka, Laura A. Skerlos, Hinnah Campwala, Nicola Bevan, Sandra Perez-Garrido, Gillian Lovell, Timothy Dale, Cicely L. Schramm, Daniel M. Appledorn, John N. Rauch, Susan K. Foltin
Publikováno v:
Cancer Research. 80:1834-1834
The ability to perform concurrent, dynamic measurements of multiple parameters of tumor cell health can provide valuable mechanistic insight. For example, a single compound may exhibit cytotoxic and/or cytostatic properties, depending on the tumor ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07c411a5c2ca67e3421c76984a0d5930
https://doi.org/10.1158/1538-7445.am2020-1834
https://doi.org/10.1158/1538-7445.am2020-1834